Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (161-170 of 255) with videos related to

Pageof 26
Sort By:
European Urology|July 1, 2011
Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancerGregory R Pond, Andrew J Armstrong, Brian A Wood, et al.
Plos One|February 3, 2022
A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancerVeeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D Clement, et al.
Cancer Research|February 21, 2006
Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptorsAaron D Schimmer, Michael P Thomas, Rose Hurren, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 2, 2024
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort StudyHira Mian, Hsien Seow, Gregory R Pond, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast CancerRicardo Fernandes, Terry L Ng, Mashari Jemaan Alzahrani, et al.
Cureus|December 8, 2018
Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial CancerElysia Donovan, Clare J Reade, Lua R Eiriksson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled StudyJanette L Vardy, Haryana M Dhillon, Gregory R Pond, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancerBrandon M Meyers, Humaid O Al-Shamsi, Sara Rask, et al.
Breast Cancer Research and Treatment|August 9, 2019
A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patientsAngel Arnaout, Susan J Robertson, Gregory R Pond, et al.
JAMA Oncology|July 29, 2021
Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical TrialTheodoros Tsakiridis, Gregory R Pond, Jim Wright, et al.
Pageof 26

Showing results (161-170 of 255) with videos related to

Sort By:
Pageof 26
European Urology|July 1, 2011
Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancerGregory R Pond, Andrew J Armstrong, Brian A Wood, et al.
Plos One|February 3, 2022
A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancerVeeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D Clement, et al.
Cancer Research|February 21, 2006
Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptorsAaron D Schimmer, Michael P Thomas, Rose Hurren, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 2, 2024
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort StudyHira Mian, Hsien Seow, Gregory R Pond, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast CancerRicardo Fernandes, Terry L Ng, Mashari Jemaan Alzahrani, et al.
Cureus|December 8, 2018
Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial CancerElysia Donovan, Clare J Reade, Lua R Eiriksson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled StudyJanette L Vardy, Haryana M Dhillon, Gregory R Pond, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancerBrandon M Meyers, Humaid O Al-Shamsi, Sara Rask, et al.
Breast Cancer Research and Treatment|August 9, 2019
A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patientsAngel Arnaout, Susan J Robertson, Gregory R Pond, et al.
JAMA Oncology|July 29, 2021
Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical TrialTheodoros Tsakiridis, Gregory R Pond, Jim Wright, et al.
Pageof 26